Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02497417 · ClinicalTrials.gov registry record
A Multi-Site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients
A clinical trial, sponsored by Luminex Corporation.
- Completed
- Registry status
- 1,021
- Enrollment target
NCT02497417: Completed study, sponsored by Luminex Corporation.
NCT02497417 is a clinical trial that has completed, run by Luminex Corporation. The registered enrollment target is 1,021 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02497417 has completed, sponsored by Luminex Corporation.
- COMPLETED
- Registry status
- 1,021 participants
- Enrollment target
Study Summary
The ARIES C. difficile Assay is a real-time PCR based qualitative in vitro diagnostic test for the direct detection of C. difficile nucleic acid in stool specimens.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,021 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-02 |
What the finished NCT02497417 record still lists
NCT02497417 is an observational study that tracks outcomes without assigning an intervention. Its 1,021 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02497417 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02497417 about?
NCT02497417 is a clinical study titled "A Multi-Site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients". The ARIES C. difficile Assay is a real-time PCR based qualitative in vitro diagnostic test for the direct detection of C. difficile nucleic acid in stool specimens.
What is the current status of trial NCT02497417?
This trial is currently completed. The enrollment target is 1,021 participants. The study started on 2016-10. Estimated completion is 2017-02.
Who is sponsoring clinical trial NCT02497417?
This trial is sponsored by Luminex Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02178163 · 1,020 participants · NA
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
- NCT05225428 · 1,020 participants · NA
Video Education With Result Dependent dIsclosure
- NCT06697600 · 1,020 participants · NA
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
- NCT06760637 · 1,020 participants · Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia